BioSpace News Archive

Technavio has announced its latest market research report titled global CT scanners market 2020-2024.

Study expands on recently published preclinical data that showed improvements in aerobic performance following supplementation with ChromaDex’s novel form of vitamin B3

Technavio has announced its latest market research report titled global galacto-oligosaccharide market 2020-2024.

Epizyme, Inc. announced that it exercised its option to sell $50 million of its common stock to Royalty Pharma, pursuant to the terms of the companies’ recent funding agreements announced on November 4, 2019.

Lannett Company, Inc. announced that it has commenced marketing Venlafaxine Extended Release Tablets, 150 mg and 225 mg, USP, and Lidocaine Topical Solution 4%.

Parallax Health Sciences, Inc., an outcome-driven connected healthcare company, announced its intent at asserting and monetizing its intellectual property patent rights within the Human Diagnostics and Behavioral Healthcare markets.

Sorrento Therapeutics announced that its partner Mabpharm filed recently a New Drug Application for the Infliximab biosimilar antibody in China.

Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) (“Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines based on cancer cell biology, announces that the Company will present at Biotech Showcase™ 2020, at 9:30 a.m. PT on January 13,

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body’s immune system in the fight against cancer, today announced that data from studies utilizing Cchek™, the company’s artificial intelligence (AI) driven cancer detection technology, will be presented at the American Association for Cancer Research (AACR) Special Conference

CollPlant, a regenerative medicine company, announced it is now part of a new public-private ManufacturingUSA initiative, the Advanced Regenerative Manufacturing Institute.